References
- Cohen M. L., Kurz K. D. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J. Pharmacol. Exp. Ther. 1982; 220: 63–69
- Unger T., Ganten O., Lang R. E., Schölkens B. A. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe 498 and MK-421, in spontaneously hypertensive rats. J. Cardiovascular Pharmacol. 1984; 6: 872–880
- Unger T., Kaufmann-Bühler I., Schölkens B., Ganten O. Brain converting enzyme inhibition: A possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Eur. J. Pharmacol. 1981; 70: 467–478
- Cohen M. L., Wiley K. S., Kurz K. D. Effect of acute oral administration of captopril and MK-421 on vascular angiotensin converting enzyme activity in the spontaneously hypertensive rat. Life Sci. 1983; 32: 565–569